Atherosclerosis and Lipoproteins |
From the Cardiff School of Biosciences, Cardiff University, United Kingdom.
Correspondence to Dipak P. Ramji, Cardiff School of Biosciences, Cardiff University, Museum Avenue, Cardiff CF10 3US, UK. E-mail Ramji{at}cardiff.ac.uk
Objective The cytokine transforming growth factor-ß (TGF-ß) and apolipoprotein E (apoE) play potent antiatherogenic roles. Despite such importance, the mechanisms underlying the regulation of apoE expression by TGF-ß have not been characterized and were therefore investigated.
Methods and Results Using THP-1 cell line as a model system, with key findings confirmed in primary cultures, we show that TGF-ß induces the expression of apoE, and this is prevented by pharmacological inhibitors of c-Jun N-terminal kinase (JNK), p38 kinase, and casein kinase 2 (CK2). In support for an important role for these pathways, TGF-ß activates JNK, p38 kinase, and CK2, and dominant-negative (DN) forms of these proteins inhibit the cytokine-induced apoE expression. TGF-ß also increases the phosphorylation and expression of c-Jun, a downstream target for JNK action and a component of activator protein-1 (AP-1), and DN c-Jun inhibits the induction of apoE expression in response to the cytokine. AP-1 DNA binding was also induced by TGF-ß, and the action of p38 kinase, JNK, and CK2 converged on the activation of c-Jun/AP-1.
Conclusions These studies reveal a novel role for JNK, p38 kinase, CK2, and c-Jun/AP-1 in the TGF-ßinduced expression of apoE.
The mechanisms underlying the regulation of apolipoprotein E expression in monocytes/macrophages by the antiatherogenic cytokine TGF-ß were investigated. We show a novel role for JNK, p38 kinase, CK2, and c-Jun/AP-1 in the response, which have implications to the development of atherosclerosis.
Key Words: apolipoprotein E atherosclerosis macrophage TGF-ß signal transduction gene expression
This article has been cited by other articles:
![]() |
M. Kockx, W. Jessup, and L. Kritharides Regulation of Endogenous Apolipoprotein E Secretion by Macrophages Arterioscler Thromb Vasc Biol, June 1, 2008; 28(6): 1060 - 1067. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Antonson, T. Jakobsson, T. Almlof, K. Guldevall, K. R. Steffensen, and J.-A. Gustafsson RAP250 Is a Coactivator in the Transforming Growth Factor {beta} Signaling Pathway That Interacts with Smad2 and Smad3 J. Biol. Chem., April 4, 2008; 283(14): 8995 - 9001. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Drosatos, D. Sanoudou, K. E. Kypreos, D. Kardassis, and V. I. Zannis A Dominant Negative Form of the Transcription Factor c-Jun Affects Genes That Have Opposing Effects on Lipid Homeostasis in Mice J. Biol. Chem., July 6, 2007; 282(27): 19556 - 19564. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. J. Harvey, N. Li, and D. P. Ramji Critical Role for Casein Kinase 2 and Phosphoinositide-3-Kinase in the Interferon-{gamma}-Induced Expression of Monocyte Chemoattractant Protein-1 and Other Key Genes Implicated in Atherosclerosis Arterioscler Thromb Vasc Biol, April 1, 2007; 27(4): 806 - 812. [Abstract] [Full Text] [PDF] |
||||
|
ATVB Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2006 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |